MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: A pilot microarray study and confirmation in a 32 patient cohort

Experimental and Molecular Medicine

Volumn 47, Issue 2, 2015, Pages

  Han, Hui ^a   Qu, Guangjin ^a   Han, Chenghua ^a   Wang, Yuhong ^a   Sun, Tingting ^a   Li, Fengqing ^a   Wang, Junxiao ^a   Luo, Shanshun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; MICRORNA; MICRORNA 106B; MICRORNA 21; MICRORNA 23A; MICRORNA 30A; MICRORNA 34A; UNCLASSIFIED DRUG; MIRN21 MICRORNA, HUMAN; MIRN23 MICRORNA, HUMAN; MIRN34 MICRORNA, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; GENE EXPRESSION; HUMAN; KNOCKOUT MOUSE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PILOT STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CASE CONTROL STUDY; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; REPRODUCIBILITY; RISK FACTOR;

MUS;

AGED; ANIMALS; APOLIPOPROTEINS E; BIOMARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; MIDDLE AGED; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 84928012213     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2014.81     Document Type: Article

References (59)

1. Sun X, Zhang M, Sanagawa A, Mori C, Ito S, Iwaki S et al. Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb J 2012;10:16.
2. Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU et al. Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci 2010;119:335-343.
3. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003;290:2292-2300.
4. Aiello RJ, Brees D, Bourassa PA, Royer L, Lindsey S, Coskran T et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 2002;22:630-637.
5. Joyce CW, Wagner EM, Basso F, Amar MJ, Freeman LA, Shamburek RD et al. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis. J Biol Chem 2006;281:33053-33065.
6. Chang TC, Mendell JT. microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 2007;8:215-239.
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
8. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008;36:D154-D158.
9. Wang J, Yang X. The function of miRNA in cardiac hypertrophy. Cell Mol Life Sci 2012;69:3561-3570.
10. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
11. Marsit CJ, Eddy K, Kelsey KT. MicroRNA responses to cellular stress. Cancer Res 2006;66:10843-10848.
12. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003;113:25-36.
13. Artmann S, Jung K, Bleckmann A, Beissbarth T. Detection of simultaneous group effects in microRNA expression and related target gene sets. PLoS ONE 2012;7:e38365.
14. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA 2010;107:13450-13455.
15. Han H, Wang YH, Qu GJ, Sun TT, Li FQ, Jiang W et al. Differentiated miRNA expression and validation of signaling pathways in apoE gene knockout mice by cross-verification microarray platform. Exp Mol Med 2013;45:e13.
16. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579-1588.
17. Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 2009;83:131-139.
18. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
19. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008;3:e3148.
20. Bea F, Blessing E, Bennett B, Levitz M, Wallace EP, Rosenfeld ME. Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering. Arterioscler Thromb Vasc Biol 2002;22:1832-1837.
21. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007;31:367-373.
22. Raitoharju E, Lyytikainen LP, Levula M, Oksala N, Mennander A, Tarkka M et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011;219:211-217.
23. Bronze-da-Rocha E. MicroRNAs expression profiles in cardiovascular diseases. Biomed Res Int 2014;2014:985408.
24. Xu J, Zhao J, Evan G, Xiao C, Cheng Y, Xiao J. Circulating microRNAs: novel biomarkers for cardiovascular diseases. J Mol Med 2012;90:865-875.
25. Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, Aukrust P et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 2010;394:792-797.
26. ∗. PloS one 2011;6:e25946.
27. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011;124:1936-1944.
28. D'Alessandra Y, Carena MC, Spazzafumo L, Martinelli F, Bassetti B, Devanna P et al. Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina. PloS one 2013;8:e80345.
29. Diehl P, Fricke A, Sander L, Stamm J, Bassler N, Htun N et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012;93:633-644.
30. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007;116:258-267.
31. Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 2009;284:29514-29525.
32. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 2010;87:431-439.
33. Zile MR, Mehurg SM, Arroyo JE, Stroud RE, DeSantis SM, Spinale FG. Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circ Cardiovasc Genet 2011;4:614-619.
34. Olivieri F, Antonicelli R, Capogrossi MC, Procopio AD. Circulating micro-RNAs (miRs) for diagnosing acute myocardial infarction: an exciting challenge. Int J Cardiol 2013;167:3028-3029.
35. Villar AV, García R, Merino D, Llano M, Cobo M, Montalvo C et al. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int J Cardiol 2013;167:2875-2881.
36. Long G, Wang F, Duan Q, Yang S, Chen F, Gong W et al. Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PloS one 2012;7:e50926.
37. Zhao DS, Chen Y, Jiang H, Lu JP, Zhang G, Geng J et al. Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure. Cardiovasc Pathol 2013;22:444-450.
38. Busk PK, Cirera S. MicroRNA profiling in early hypertrophic growth of the left ventricle in rats. Biochem Biophys Res Commun 2010;396:989-993.
39. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T et al. Human villous trophoblasts express and secrete placenta-specific micro-RNAs into maternal circulation via exosomes. Biol Reprod 2009;81:717-729.
40. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 2008;377:114-119.
41. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Korner H et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell cycle 2008;7:2591-2600.
42. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010;17:193-199.
43. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009;104:476-487.
44. Weber M, Baker MB, Moore JP, Searles CD. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 2010;393:643-648.
45. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23 ∼ 27 ∼ 24 clusters. Proc Natl Acad Sci USA 2011;108:8287-8292.
46. Ren J, Zhang J, Xu N, Han G, Geng Q, Song J et al. Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PloS one 2013;8:e80738.
47. Slagsvold KH, Johnsen AB, Rognmo O, Høydal M, Wisløff U, Wahba A. Comparison of left versus right atrial myocardium in patients with sinus rhythm or atrial fibrillation - an assessment of mitochondrial function and microRNA expression. Physiol Rep 2014;2:e12124.
48. Dickinson BA, Semus HM, Montgomery RL, Stack C, Latimer PA, Lewton SM et al. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur J Heart Fail 2013;15:650-659.
49. Zhang H, Yang H, Zhang C, Jing Y, Wang C, Liu C et al. Investigation of MicroRNA Expression in Human Serum During the Aging Process. J Gerontol A Biol Sci Med Sci 2014, pii: glu145.
50. Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X et al. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2. Cancer Sci 2014;105:18-25.
51. Wang JL, Hu Y, Kong X, Wang ZH, Chen HY, Xu J et al. Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study. PloS one 2013;8:e73683.
52. Rotllan N, Fernández-Hernando C. MicroRNA Regulation of Cholesterol Metabolism. Cholesterol 2012;2012:847849.
53. Liu Z, Yang D, Xie P, Ren G, Sun G, Zeng X et al. MiR-106b and MiR-15b modulate apoptosis and angiogenesis in myocardial infarction. Cell Physiol Biochem 2012;29:851-862.
54. Luan S, Sun L, Huang F. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res 2010;41:67-74.
55. Aranha MM, Santos DM, Sola S, Steer CJ, Rodrigues CM. miR-34a regulates mouse neural stem cell differentiation. PLoS ONE 2011;6:e21396.
56. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447:1130-1134.
57. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR et al. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PloS one 2012;7:e29770.
58. Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES et al. Circulating microRNAs as specific biomarkers for breast cancer detection. PloS one 2013;8:e53141.
59. Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT et al. Serum microRNA biomarkers for detection of non-small cell lung cancer. PloS one 2012;7:e32307.